Less than 1% of the phenylephrine is absorbed into the bloodstream after being swallowed, they estimated. Far higher doses could "be needed to achieve a clinically meaningful outcome which would raise significant questions about safety."

"Furthermore, there are no clinical data demonstrating that oral PE is effective as a nasal decongestant at any dosage," the FDA's scientists wrote. (CBS News | ALEXANDER TIN)